Brief overviews of RDA BioSharing WG and RDA Metabolomics IG for RDA Pleanary 4; IGs and WGs chair session (Sunday) and ELIXIR IG breakout (Tuesday)

1. The BioSharing Registry: connecting
data policies, standards and databases in the life sciences
The product of the WG will be a web-based, curated and searchable
registry of content standards ensuring these are informative and
discoverable, monitoring their development, evolution; their use in
databases and adoption in data policies.

2. Goal: assist stakeholders to make informed decisions
Researchers, developers and curators lack support and guidance on how to best navigate and
select content standards, understand their maturity, or find databases that implement them;
Funders, journals and librarians do not have enough information to make informed decisions
on which content standards or database to recommended in policies, or funded or implemented

3. Leveraging on an existing effort:
Current content:
• Over 500
• Over 600
databases MoU with
The International Conference on Systems Biology (ICSB), 22-28 August, 2008 Susanna-Assunta
Sansone www.ebi.ac.uk/net-project
3
Current core functionalities:
• search and filtering
• submissions forms to add new records
• “claim” functionality of existing records
• person’s profile (as maintainer of
records) associated to the ORCID
profile
• visualization and views of content
Work to be done under in the RDA WG includes (but it is not limited to):
• Develop assessment criteria for usability and popularity of standards
• Assemble journal and funder policies re data storage
• Associate standards to data policies and databases
• Make fully cross-searchable
• Continue to embed it in the ecosystem of complementary registries

4. Advisory Board and RDA Working Group core members – also early adopters
Operational Team

5. The Metabolomics Data Interoperability IG: aims
Christoph Steinbeck (chair), EMBL-EBI
Shankar Subramanian (co-chair), University of California San Diego
Susanna-Assunta Sansone (RDA community liaise), University of Oxford
This IG aims to provide a forum to discuss all aspects of metabolomics data
management and harmonization, focusing on barriers and potential solutions to
those barriers, and exploration of and definition of data management policy
In particular this IG will address:
• interoperability of databases;
• coordination of standards, e.g. convergence on shared terminology;
• adaption of common tools and services, and workflows
to enable data exchange, integration and publication.
This IG will liaise with other existing technical and domain specific IGs and WGs
under RDA, including (but not limited to) Big Data Analytics IG, Data Foundation
and Terminology WG, Toxicogenomics IG, ELIXIR IG and will also bridge with
external, existing world-wide activities

6. Initial memberships and links to existing efforts
The initial membership of this IG is drawn from the leaders of several
internationally recognized research and infrastructure programmes that are
developing metabolomics databases and standards, such as the NIH Common
Fund Metabolomics and ELIXIR, as well as from the International
Metabolomics Society’s Board of Directors
Masanori Arita, National Institute of Genetics, Japan
Warwick Dunn, University of Birmingham, UK (Director of Metabolomics Society)
Oliver Fiehn, UC Davis, USA (Director of Metabolomics Society)
Roy Goodacre, University of Manchester, UK (Director of Metabolomics Society)
Jules Griffin, MRC Human Nutrition Research, UK
Ulrich Günther, University of Birmingham, UK
Thomas Hankemeier, Leiden University, Netherlands
Kenneth Haug, EMBL-EBI, UK
Joachim Kopka, Max-Planck-Institute of Molecular Plant Physiology, Germany
Steffen Neumann, Leibniz Institute of Plant Biochemistry
Philippe Rocca-Serra, University of Oxford, UK
Ute Roessner, University of Melbourne, Australia (Secretary of Metabolomics Society)
Reza Salek, EMBL-EBI, UK
Susanna-Assunta Sansone (RDA community liaise), University of Oxford
Christoph Steinbeck (chair), EMBL-EBI
Shankar Subramanian (co-chair), University of California San Diego
Merlijn van Rijswijk, Dutch Techcentre for Life Sciences, Utrecht, Netherlands
Mark Viant, University of Birmingham, UK (President of Metabolomics Society)
Dirk Walther, Max-Planck-Institute of Molecular Plant Physiology, Germany
David Wishart, University of Alberta, Canada